Showing results (151-160 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|February 4, 2009
WebFlow: a software package for high-throughput analysis of flow cytometry dataMark M Hammer, Nikesh Kotecha, Jonathan M Irish, et al.
Assay and Drug Development Technologies|October 15, 2013
Expression and purification of recombinant human apolipoprotein A-II in Pichia pastorisManman Su, Yitian Qi, Mingxing Wang, et al.
Assay and Drug Development Technologies|November 16, 2013
High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cellsOksana Sirenko, Jayne Hesley, Ivan Rusyn, et al.
Assay and Drug Development Technologies|June 10, 2009
Discovery and development of an aurora kinase inhibitor clinical candidate using an image-based assay for measuring proliferation, apoptosis, and DNA contentSusan M Catalano, John McLaughlin, Yasumichi Hitoshi, et al.
Assay and Drug Development Technologies|May 21, 2010
Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assaySuja Elizabeth George, Rosaleen J Anderson, Anne Cunningham, et al.
Assay and Drug Development Technologies|May 21, 2010
A plate-based assay to measure cellular ERK substrate phosphorylation: utility for drug discovery of the MAPK-signaling cascadeSreemathy Ramaswamy, Ivana Yen, Steve Sideris, et al.
Assay and Drug Development Technologies|May 21, 2010
Strategy for the identification of GPR23/LPA4 receptor agonists and inverse agonistsSoo Hang Wong, Rommel Mallari, Melissa Graham, et al.
Assay and Drug Development Technologies|June 18, 2009
A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockersFrancesco Belardetti, Elizabeth Tringham, Cyrus Eduljee, et al.
Assay and Drug Development Technologies|July 17, 2009
An interview with Michael M. Gottesman, M.D. Interview by Vicki GlaserMichael M Gottesman
Assay and Drug Development Technologies|June 29, 2010
A 1,536-well ultra-high-throughput siRNA screen to identify regulators of the Wnt/beta-catenin pathwayNamjin Chung, Shane Marine, Emily A Smith, et al.
Pageof 100